Michael D. Nelson
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (11)
Year:
2023
Stroke volume decreases and end-systolic volume increases during muscle metaboreflex activation in patients with heart failure with reduced ejection fraction (HFrEF), suggesting impaired contractile reserve during muscle metaboreflex activation in patients with HFrEF. Total peripheral resistance increases similarly during muscle metaboreflex activation in patients with HFrEF compared to controls, indicating normal levels of peripheral vasoconstriction during muscle metaboreflex activation in patients with HFrEF.
Year:
2023
Mounting evidence suggests that myocardial steatosis contributes to left ventricular diastolic dysfunction, but definitive evidence in humans is lacking due to confounding comorbidities. As such, we utilized a 48‐h food restriction model to acutely increase myocardial triglyceride (mTG) content – measured by 1 H magnetic resonance spectroscopy – in 27 young healthy volunteers (13 men/14 women). Forty‐eight hours of fasting caused a more than 3‐fold increase in mTG content ( P < 0.001). Diastolic function – defined as early diastolic circumferential strain rate (CSRd) – was unchanged following the 48‐h fasting intervention, but systolic circumferential strain rate was elevated ( P < 0.001), indicative of systolic–diastolic uncoupling. Indeed, in a separate control experiment in 10 individuals, administration of low‐dose dobutamine (2 μg/kg/min) caused a similar change in systolic circumferential strain rate as was found during 48 h of food restriction, along with a proportionate increase in CSRd, such that the two metrics remained coupled. Taken together, these data indicate that myocardial steatosis contributes to diastolic dysfunction by impairing diastolic–systolic coupling in healthy adults, and suggest that steatosis may contribute to the progression of heart disease. image Key points Preclinical evidence strongly suggests that myocardial lipid accumulation (termed steatosis ) is an important mechanism driving heart disease. Definitive evidence in humans is limited due to the confounding influence of multiple underlying comorbidities. Using a 48‐h food restriction model to acutely increase myocardial triglyceride content in young healthy volunteers, we demonstrate an association between myocardial steatosis and left ventricular diastolic dysfunction. These data advance the hypothesis that myocardial steatosis may contribute to diastolic dysfunction and suggest myocardial steatosis as a putative therapeutic target.
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Collaborators (11)
Ryosuke Takeda
Chukyo University
Carol North
Professor
University of Texas Southwestern Medical Center
Jakub Kolarik
VSB - Technical University of Ostrava
Martina Ládrová
VSB - Technical University of Ostrava
R. Matthew Brothers
-
Naomi Hamburg
Associate Professor of Medicine
Boston University
Mark Haykowsky
Professor, Endowed Research Chair in Aging & Quality of Life
University of Alberta
Corey R. Tomczak
-
Andrew W. D'Souza
-
Ziyad Ben Taleb
-
Kerrie L. Moreau
University of Colorado Anschutz Medical Campus
Make your next move.
Prepare your application
Review drafts before you send them.